Recognition of the importance of embolization in atherosclerotic vascular disease.
about
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightDebate: PCI vs CABG: a moving target, but we are gainingNo-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial InfarctionCardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic CardiomyopathyMagnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologiesLarge intracoronary thrombi with good TIMI flow during acute myocardial infarction: four cases of successful aggressive medical management in patients without angiographically detectable coronary atherosclerosisGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyTreatment of microvascular micro-embolization using microbubbles and long-tone-burst ultrasound: an in vivo study.Progress in atherosclerotic plaque imaging.Automatic detection of microemboli during percutaneous coronary interventions.Percutaneous coronary intervention in st-elevation myocardial infarction.Intermediate and high peri-operative cardiac enzyme release following isolated coronary artery bypass surgery are independently associated with higher one-year mortalitySafety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trialsTASTE: To aspirate, or not to aspirate, remains a question.Major depression and coronary flow reserve detected by positron emission tomography.Treatment strategies for microvascular dysfunction following acute myocardial infarction.Establishment and characterization of an experimental model of coronary thrombotic microembolism in rats.The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised cRisk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.The "no-reflow" phenomenon: basic science and clinical correlates.Clinical implications of the new definition of myocardial infarction.Early invasive strategies for acute coronary syndromes.The use of the glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary intervention.Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.Percutaneous coronary intervention or thrombolytics in ST-elevation infarction. What is the emperor really wearing?Renovascular hypertension and ischemic nephropathy.Relationship between surface area of nonperfused myocardium and extravascular extraction of contrast agent following coronary microembolizationCurrent concepts of mechanical cerebral protection during precutaneous carotid intervention.Determining microvascular obstruction and infarct size with steady-state free precession imaging cardiac MRI.Randomised comparison of coronary stenting with and without balloon predilatation in selected patients.Prognostic implication of cardiac troponin T increase following stent implantation.Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring.Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions.Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices.Noncardiac applications of glycoprotein IIb/IIIa inhibitors.Microvascular alterations after temporary coronary artery occlusion: the no-reflow phenomenon.Effect of a distal protection device on epicardial blood flow and myocardial perfusion in primary percutaneous coronary intervention.Role of PET in the evaluation and understanding of coronary physiology.Management of cardiogenic shock due to acute coronary syndromes.
P2860
Q24799198-F0122C4E-57BA-4C10-919A-BB98220FE5C7Q24799287-67FAF93D-CCDA-4735-9CAD-8D1ED75634A2Q26766631-70F04E0C-DCC6-4C27-AC1F-14E9239A6B74Q26801712-42495312-7150-4F83-A7E4-32944FD269DFQ26824231-821B557D-87D5-433C-B896-C0F6A57B70D4Q28193948-5E1BBCD4-C3E7-4C65-A1FB-6F5F7911C783Q28239975-92918268-BD73-4086-9B9D-D989795CB20DQ30412302-6709630E-D797-4E55-8544-FD165B0CC05DQ30464390-F8CA461D-802A-42A2-853B-937B328783B3Q30834680-26CCF938-B7A5-4C83-85E7-035CF06262F7Q30992688-FC5D772A-DF13-4FBA-9748-52EA7475E856Q33254062-9A5579D3-8194-411F-9886-96824BEB24FFQ33534873-D5EB274C-3CA5-44C7-B9DE-9D5E2DF12558Q33923781-FAC62914-8738-42DD-B647-725CAE70B9C6Q33972521-57AD1832-6382-4C57-B909-83E5F1212371Q34027535-CE7F92D9-26C0-473B-87D6-1DC2FE2E9909Q34086859-2D6C0FED-5AEB-4098-8217-512166940B9BQ34305843-0F989ECA-6A2C-4E47-A68A-0D47B462A23AQ34445660-FCAD4D9F-BC09-4528-8EFB-D8DF367FBF9AQ34498288-F85C11E6-5235-447B-A623-294770948FAEQ34543932-BB54C1E9-51A5-4E60-B4FA-39EBC3164BA4Q34674187-00A3D5E4-3CB1-43D2-9A6D-60479EF197CDQ34675290-1C4803AC-1BE6-4D5E-8F07-8918570F4C68Q34759513-319E8B09-E9B9-478C-9CAA-6C196B04BB69Q34803104-7191A5DA-3131-40A5-9580-B45D2555C856Q34807128-2D0D7C29-2FA2-4FA0-947E-4ABE48944F10Q35160059-6F8C3919-0255-4267-B9EB-0757D509ABC1Q35179211-8C95B830-DDEF-482C-8218-7BDFA5BA39ECQ35202297-7892159B-9005-43D0-B9DA-C06608D00A44Q35380978-1B819C67-8931-48E3-8386-4290AD829ECAQ35579996-3846A221-D07A-4558-93B0-F2F5EB7612C3Q35582491-65F9E00B-399B-4679-8E19-FDFEB302B994Q35582508-094EF96D-FECA-47C9-8F48-DED6BEFFEA90Q35584697-978B58ED-9F7C-461B-AB1B-3A3EF634D46AQ35820782-98D9D617-2D5F-4087-B7CF-664BAF6814B8Q35845678-DD2DC003-09AE-43C3-A2F4-85718CEFDD5EQ35892175-7E2A5929-E5AF-4D03-AC97-9C1DC47D8C90Q35916882-29952859-042E-49BD-8FF2-833EF492200FQ36017117-F6A3E25B-1325-40DF-8833-0D718BE6E878Q36081588-3794A9A3-AA1C-40E7-89FC-4597598FB876
P2860
Recognition of the importance of embolization in atherosclerotic vascular disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recognition of the importance of embolization in atherosclerotic vascular disease.
@ast
Recognition of the importance of embolization in atherosclerotic vascular disease.
@en
type
label
Recognition of the importance of embolization in atherosclerotic vascular disease.
@ast
Recognition of the importance of embolization in atherosclerotic vascular disease.
@en
prefLabel
Recognition of the importance of embolization in atherosclerotic vascular disease.
@ast
Recognition of the importance of embolization in atherosclerotic vascular disease.
@en
P356
P1433
P1476
Recognition of the importance of embolization in atherosclerotic vascular disease.
@en
P2093
P304
P356
10.1161/01.CIR.101.5.570
P407
P50
P577
2000-02-01T00:00:00Z